News
We continue to be sell-rated on Advanced Micro Devices, Inc. (NASDAQ:AMD) post the company’s Data Center and A.I. technology Premiere. Despite AMD CEO Lisa...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Élé Asu Good morning, ladies and gentlemen. Welcome to this Thema dedicated to Innovation for Environmental Security. And thank you for joining us remotely...
News
This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
News
This article was written by Follow Robert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered...
News
In the 2000 movie “Boiler Room,” a shady stockbroker scams a hapless investor into losing his life savings. Pressured by the broker, the investor...
News
If you are looking for an under-covered stock secured by a company with a substantial market share in a niche industry, then you’re in...
News
America May Now Be in a Youth-Cession: Consumers Over Age 60 Are Propping Up the Economy A big factor in the recent spending patterns...
News
The Kraft Heinz Company (NASDAQ:KHC) Evercore ISI 3rd Annual Consumer and Retail Conference June 15, 2023 1:15 PM ET Company Participants Andre Maciel –...
News
Millions of borrowers are awaiting an imminent decision by the Supreme Court on a pair of legal challenges to President Joe Biden’s signature student...
News
~ by Snehasish Chaudhuri, MBA (Finance). iShares Mortgage Real Estate Capped ETF (BATS:REM) is an exchange-traded fund (“ETF”) that invests in stocks of mortgage...
News
President Joe Biden will announce efforts Thursday to crack down on “junk fees” — hidden or obscure fees that surprise consumers when they’re buying...
News
Lanxess Aktiengesellschaft (OTCPK:LNXSF) has had some recent activity that signals value for the business on private markets. They created a J.V with Advent by...
News
Belite Bio (NASDAQ:BLTE) is a small company with multiple phase 3 trials targeting retinal degenerative eye diseases. The stock looks interesting, with late-stage trials...
